| William D Barrett, MD | |
|
61 Court Dr, Brandon, VT 05733-8407 | |
| (802) 247-3755 | |
| (802) 247-4560 |
| Full Name | William D Barrett |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 61 Court Dr, Brandon, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598754988 | NPI | - | NPPES |
| 0004669 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Vermont) | Primary |
| Entity Name | Porter Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235159567 PECOS PAC ID: 1850365180 Enrollment ID: O20050620000111 |
News Archive
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
In an "Insight" feature article, Reuters examines how new information on the prevention benefits of HIV treatment and other strategies, such as male circumcision, "could finally break the back of the AIDS epidemic."
Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.
It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.
Osteoarthritis is a disease of the whole joint, typified by structural alterations in bone, ligaments, and joints, that render them weak. In its severe form, it is extremely debilitating for patients, resulting in hindered mobility and the incidence of severe pain.
› Verified 7 days ago
| Entity Name | Porter Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841210176 PECOS PAC ID: 1850365180 Enrollment ID: O20050919000736 |
News Archive
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
In an "Insight" feature article, Reuters examines how new information on the prevention benefits of HIV treatment and other strategies, such as male circumcision, "could finally break the back of the AIDS epidemic."
Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.
It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.
Osteoarthritis is a disease of the whole joint, typified by structural alterations in bone, ligaments, and joints, that render them weak. In its severe form, it is extremely debilitating for patients, resulting in hindered mobility and the incidence of severe pain.
› Verified 7 days ago
| Entity Name | Porter Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134457013 PECOS PAC ID: 1850365180 Enrollment ID: O20050919000862 |
News Archive
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
In an "Insight" feature article, Reuters examines how new information on the prevention benefits of HIV treatment and other strategies, such as male circumcision, "could finally break the back of the AIDS epidemic."
Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.
It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.
Osteoarthritis is a disease of the whole joint, typified by structural alterations in bone, ligaments, and joints, that render them weak. In its severe form, it is extremely debilitating for patients, resulting in hindered mobility and the incidence of severe pain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William D Barrett, MD 104 Porter Dr, Middlebury, VT 05753-8527 Ph: (802) 388-8808 | William D Barrett, MD 61 Court Dr, Brandon, VT 05733-8407 Ph: (802) 247-3755 |
News Archive
Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler in patients with moderate-to-severe COPD.
In an "Insight" feature article, Reuters examines how new information on the prevention benefits of HIV treatment and other strategies, such as male circumcision, "could finally break the back of the AIDS epidemic."
Delcath Systems, Inc., a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath's Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO's 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago.
It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.
Osteoarthritis is a disease of the whole joint, typified by structural alterations in bone, ligaments, and joints, that render them weak. In its severe form, it is extremely debilitating for patients, resulting in hindered mobility and the incidence of severe pain.
› Verified 7 days ago
Kim Kurak, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Grove St, Brandon, VT 05733 Phone: 802-247-6305 Fax: 802-247-6040 | |
Lucy Mckeon, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 61 Court Dr, Brandon, VT 05733 Phone: 802-247-3755 | |
George C Fjeld, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 420 Grove St, Brandon, VT 05733 Phone: 802-247-6305 Fax: 802-247-6040 | |
Carrie C Wulfman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 61 Court Dr, Brandon, VT 05733 Phone: 802-247-3756 Fax: 802-247-4560 |